These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1244 related items for PubMed ID: 31636208

  • 1. Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies.
    Wei SC, Anang NAS, Sharma R, Andrews MC, Reuben A, Levine JH, Cogdill AP, Mancuso JJ, Wargo JA, Pe'er D, Allison JP.
    Proc Natl Acad Sci U S A; 2019 Nov 05; 116(45):22699-22709. PubMed ID: 31636208
    [Abstract] [Full Text] [Related]

  • 2. Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.
    Wei SC, Levine JH, Cogdill AP, Zhao Y, Anang NAS, Andrews MC, Sharma P, Wang J, Wargo JA, Pe'er D, Allison JP.
    Cell; 2017 Sep 07; 170(6):1120-1133.e17. PubMed ID: 28803728
    [Abstract] [Full Text] [Related]

  • 3. Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma.
    Kondo Y, Ohno T, Nishii N, Harada K, Yagita H, Azuma M.
    Oral Oncol; 2016 Jun 07; 57():54-60. PubMed ID: 27208845
    [Abstract] [Full Text] [Related]

  • 4. Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes.
    Sun NY, Chen YL, Lin HW, Chiang YC, Chang CF, Tai YJ, Chen CA, Sun WZ, Chien CL, Cheng WF.
    Cancer Lett; 2019 Mar 01; 444():20-34. PubMed ID: 30543813
    [Abstract] [Full Text] [Related]

  • 5. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
    Duraiswamy J, Kaluza KM, Freeman GJ, Coukos G.
    Cancer Res; 2013 Jun 15; 73(12):3591-603. PubMed ID: 23633484
    [Abstract] [Full Text] [Related]

  • 6. Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking.
    Taggart D, Andreou T, Scott KJ, Williams J, Rippaus N, Brownlie RJ, Ilett EJ, Salmond RJ, Melcher A, Lorger M.
    Proc Natl Acad Sci U S A; 2018 Feb 13; 115(7):E1540-E1549. PubMed ID: 29386395
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy.
    Gide TN, Quek C, Menzies AM, Tasker AT, Shang P, Holst J, Madore J, Lim SY, Velickovic R, Wongchenko M, Yan Y, Lo S, Carlino MS, Guminski A, Saw RPM, Pang A, McGuire HM, Palendira U, Thompson JF, Rizos H, Silva IPD, Batten M, Scolyer RA, Long GV, Wilmott JS.
    Cancer Cell; 2019 Feb 11; 35(2):238-255.e6. PubMed ID: 30753825
    [Abstract] [Full Text] [Related]

  • 10. Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells.
    Wang K, Coutifaris P, Brocks D, Wang G, Azar T, Solis S, Nandi A, Anderson S, Han N, Manne S, Kiner E, Sachar C, Lucas M, George S, Yan PK, Kier MW, Laughlin AI, Kothari S, Giles J, Mathew D, Ghinnagow R, Alanio C, Flowers A, Xu W, Tenney DJ, Xu X, Amaravadi RK, Karakousis GC, Schuchter LM, Buggert M, Oldridge D, Minn AJ, Blank C, Weber JS, Mitchell TC, Farwell MD, Herati RS, Huang AC.
    Cancer Cell; 2024 Sep 09; 42(9):1582-1597.e10. PubMed ID: 39214097
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxic T-Lymphocyte-Associated Antigen 4 (CTLA-4)- and Programmed Death 1 (PD-1)-Mediated Regulation of Monofunctional and Dual Functional CD4+ and CD8+ T-Cell Responses in a Chronic Helminth Infection.
    Rajamanickam A, Munisankar S, Dolla C, Nutman TB, Babu S.
    Infect Immun; 2019 Dec 09; 87(12):. PubMed ID: 31570560
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Checkpoint blockade immunotherapy enhances the frequency and effector function of murine tumor-infiltrating T cells but does not alter TCRβ diversity.
    Kuehm LM, Wolf K, Zahour J, DiPaolo RJ, Teague RM.
    Cancer Immunol Immunother; 2019 Jul 09; 68(7):1095-1106. PubMed ID: 31104075
    [Abstract] [Full Text] [Related]

  • 15. Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40.
    Messenheimer DJ, Jensen SM, Afentoulis ME, Wegmann KW, Feng Z, Friedman DJ, Gough MJ, Urba WJ, Fox BA.
    Clin Cancer Res; 2017 Oct 15; 23(20):6165-6177. PubMed ID: 28855348
    [Abstract] [Full Text] [Related]

  • 16. The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
    Mahoney KM, Freeman GJ, McDermott DF.
    Clin Ther; 2015 Apr 01; 37(4):764-82. PubMed ID: 25823918
    [Abstract] [Full Text] [Related]

  • 17. Combined targeting of costimulatory (OX40) and coinhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity.
    Redmond WL, Linch SN, Kasiewicz MJ.
    Cancer Immunol Res; 2014 Feb 01; 2(2):142-53. PubMed ID: 24778278
    [Abstract] [Full Text] [Related]

  • 18. PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?
    Tanvetyanon T, Gray JE, Antonia SJ.
    Expert Opin Biol Ther; 2017 Mar 01; 17(3):305-312. PubMed ID: 28064556
    [Abstract] [Full Text] [Related]

  • 19. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.
    Allard B, Pommey S, Smyth MJ, Stagg J.
    Clin Cancer Res; 2013 Oct 15; 19(20):5626-35. PubMed ID: 23983257
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels.
    Heeren AM, Rotman J, Stam AGM, Pocorni N, Gassama AA, Samuels S, Bleeker MCG, Mom CH, Zijlmans HJMAA, Kenter GG, Jordanova ES, de Gruijl TD.
    J Immunother Cancer; 2019 Feb 12; 7(1):43. PubMed ID: 30755279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.